Product
Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena) 52 Mg
1 clinical trial
3 indications
Indication
Atypical Endometrial HyperplasiaIndication
InfertilityIndication
ObesityClinical trial
Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical StudyStatus: Recruiting, Estimated PCD: 2024-02-28